Showing 661 - 680 results of 65,081 for search '(( 50 nn decrease ) OR ( 5 ((((step decrease) OR (we decrease))) OR (a decrease)) ))', query time: 0.65s Refine Results
  1. 661
  2. 662
  3. 663
  4. 664
  5. 665
  6. 666
  7. 667
  8. 668
  9. 669
  10. 670

    FUD transiently decreased IOP in mice injected with Ad5-TGFβ2 viral vector. by Jennifer A. Faralli (4907311)

    Published 2020
    “…(B) IOPs were monitored for 5 more days (until Day 22) in a subset of mice from A. …”
  11. 671
  12. 672

    Decreased Expression of TGR5 in Vogt-Koyanagi-Harada (VKH) Disease by Jinglu Yang (6391913)

    Published 2019
    “…</p> <p><i>Results</i>: A decreased expression of TGR5 in M1 macrophages was observed in active VKH patients as compared with normal controls. …”
  13. 673

    Force analysis of a single rib. by Jianbo Jia (717814)

    Published 2024
    “…The simulation results show that for steps of 1mm, 2mm and 3mm height, the optimal polyline angle is concentrated in the range of 10°-11°, in which the Angle of 10.5° has a good performance against the steps of three heights. …”
  14. 674
  15. 675

    Health care worker data. by Kevin Guzman (16474985)

    Published 2023
    “…<div><p>Digital adherence technologies (DATs) have emerged as an alternative to directly observed therapy (DOT) for supervisions of tuberculosis (TB) treatment. We conducted a meta-analysis of implementation feedback obtained from people with TB and health care workers (HCWs) involved in TB REACH Wave 6-funded DAT evaluation projects. …”
  16. 676

    People with TB data. by Kevin Guzman (16474985)

    Published 2023
    “…<div><p>Digital adherence technologies (DATs) have emerged as an alternative to directly observed therapy (DOT) for supervisions of tuberculosis (TB) treatment. We conducted a meta-analysis of implementation feedback obtained from people with TB and health care workers (HCWs) involved in TB REACH Wave 6-funded DAT evaluation projects. …”
  17. 677
  18. 678
  19. 679

    Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

    Published 2025
    “…However, there is concern that by neutralizing the SARS-CoV-2 virus, nMAbs may decrease the availability of antigens to the immune system, potentially impairing the endogenous polyclonal immune response and decreasing long-term immune protection.…”
  20. 680